Introduction: The idea that Helicobacter pylori (H. pylori) might confer benefit to humans by impairing iron absorption has engendered considerable controversy among investigators. The aim of the present study was to compare the seroprevalence of anti H. pylori in asymptomatic beta thalassemia major (β TM) patients and normal controls. Materials and methods: 40 proven adults β TM cases (group 1) and 40 age and sexmatched healthy controls (group 2) were the subject of the study. The mean age of adults' β TM was 21.5±4.97 years. Twenty two (55%) were males and 18 (45%) were females. Serum samples from all patients and controls were examined for specific IgG antibodies to the following H. pylori six virulent antigens: cagA (cytotoxin-associated gene A), vacA (vacuolating cytotoxin A), UreA (urease A), p30 (OMP), p25 (OMP) and p19 (OMP) using H. pylori LINE Immunoblot Assay. Serum samples from all patients were examined also for HCV-RNA viral load by Real Time PCR. Results: There was a statistically significantly higher seroprevalence of H. pylori among adult β TM patients than among the controls [14/40 (35%) vs. 9/40 (22.5%)] respectively (X 2 =82.538, p=0.000). Antibodies against cagA and vacA were absent in the healthy seropositive controls. There was no statistically significant difference between H. pylori IgG-positive (14 cases) and negative (22 cases) β TM as regards age (t=0.633, p=0.432), sex (x 2 =0.175, p=0.676), hemoglobin value (t=0.332, p=0.568), serum ferritin level (t=0.394, p=0.394) and presence of HCV. Antibodies to the six virulent antigens of H. pylori were higher in splenectomized than non splenectomized patients. Antibodies to cagA and vacA were significantly higher in splenectomized than non splenectomized patients (p=0.015 and 0.044 for cagA and vacA respectively). Conclusion: There was higher H. pylori seroprevalence in asymptomatic β-TM cases than among controls, being more frequently in splenectomized than non splenectomized patients. No difference in serum ferritin level between H. pylori seropositive and seronegative cases.